Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Hypermarcas Share Holder Equity 2010-2025 | HYPMY

Hypermarcas share holder equity from 2010 to 2025. Share holder equity can be defined as the sum of preferred and common equity items
  
Hypermarcas Annual Share Holder Equity
(Millions of US $)
2024 $2,244
2023 $2,307
2022 $2,064
2021 $1,822
2020 $1,793
2019 $2,207
2018 $2,262
2017 $2,423
2016 $2,526
2015 $2,452
2014 $3,194
2013 $3,299
2012 $3,536
2011 $3,994
2010 $2,889
2009 $1,746
Hypermarcas Quarterly Share Holder Equity
(Millions of US $)
2025-03-31 $2,004
2024-12-31 $2,244
2024-09-30 $2,203
2024-06-30 $2,304
2024-03-31 $2,367
2023-12-31 $2,307
2023-09-30 $2,335
2023-06-30 $2,234
2023-03-31 $2,082
2022-12-31 $2,064
2022-09-30 $2,003
2022-06-30 $2,076
2022-03-31 $1,895
2021-12-31 $1,822
2021-09-30 $1,854
2021-06-30 $1,811
2021-03-31 $1,711
2020-12-31 $1,793
2020-09-30 $1,730
2020-06-30 $1,689
2020-03-31 $1,985
2019-12-31 $2,207
2019-09-30 $2,181
2019-06-30 $2,184
2019-03-31 $2,237
2018-12-31 $2,262
2018-09-30 $2,076
2018-06-30 $2,244
2018-03-31 $2,439
2017-12-31 $2,423
2017-09-30 $2,542
2017-06-30 $2,447
2017-03-31 $2,712
2016-12-31 $2,526
2016-09-30 $2,787
2016-06-30 $2,590
2016-03-31 $2,323
2015-12-31 $2,452
2015-09-30 $2,209
2015-06-30 $2,710
2015-03-31 $2,460
2014-12-31 $3,194
2014-09-30 $3,271
2014-06-30 $3,274
2014-03-31 $3,034
2013-12-31 $3,299
2013-09-30 $3,074
2013-06-30 $3,368
2013-03-31 $3,496
2012-12-31 $3,536
2012-09-30 $3,330
2012-06-30 $3,421
2012-03-31 $3,791
2011-12-31 $3,994
2011-09-30 $4,070
2011-06-30 $4,254
2011-03-31 $4,049
2010-12-31 $2,889
2010-09-30 $2,871
2010-06-30 $2,760
2010-03-31 $1,955
2009-12-31 $1,746
2009-09-30 $1,446
2009-06-30 $1,034
2009-03-31 $865
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $2.907B $1.380B
Hypera S.A. is a pharmaceutical company. It engages in development of pharmaceuticals, dermocosmetics, vitamin supplements, and health products. Hypera serves customers primarily in Latin America. The company was formerly known as Hypermarcas S.A. and is headquartered in Sao Paulo, Brazil.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $84.744B 31.79
Zoetis (ZTS) United States $70.049B 26.14
Takeda Pharmaceutical (TAK) Japan $46.838B 9.32
Daiichi Sankyo, - (DSNKY) Japan $43.381B 22.23
BeOne Medicines - (ONC) Cayman Islands $28.223B 0.00
Sandoz Group AG (SDZNY) Switzerland $23.505B 0.00
Merck (MKKGY) Germany $16.394B 12.01
Summit Therapeutics (SMMT) United States $15.143B 0.00
Shionogi (SGIOY) Japan $14.700B 14.73
United Therapeutics (UTHR) United States $12.918B 11.43
Neurocrine Biosciences (NBIX) United States $12.450B 42.64
Orion OYJ (ORINY) Finland $10.594B 28.65
IPSEN (IPSEY) France $9.607B 0.00
Corcept Therapeutics (CORT) United States $7.877B 64.03
Stevanato Group S.p.A (STVN) Italy $7.099B 43.41
Madrigal Pharmaceuticals (MDGL) United States $6.283B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Ionis Pharmaceuticals (IONS) United States $5.996B 0.00
Grifols, S.A (GRFS) Spain $5.755B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.031B 15.30
Soleno Therapeutics (SLNO) United States $4.103B 0.00
Crinetics Pharmaceuticals (CRNX) United States $2.800B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.698B 9.45
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.481B 13.41
BioCryst Pharmaceuticals (BCRX) United States $2.074B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.044B 0.00
Indivior (INDV) United States $1.923B 8.16
Centessa Pharmaceuticals (CNTA) United Kingdom $1.736B 0.00
ARS Pharmaceuticals (SPRY) United States $1.627B 0.00
Endo (NDOI) United States $1.595B 0.00
Evotec AG (EVO) Germany $1.353B 0.00
Ocular Therapeutix (OCUL) United States $1.333B 0.00
Guardian Pharmacy Services (GRDN) United States $1.286B 0.00
Dyne Therapeutics (DYN) United States $1.155B 0.00
Harrow (HROW) United States $1.137B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.058B 21.16
Enliven Therapeutics (ELVN) United States $0.996B 0.00
Verve Therapeutics (VERV) United States $0.990B 0.00
Collegium Pharmaceutical (COLL) United States $0.960B 5.18
Akebia Therapeutics (AKBA) United States $0.956B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.923B 0.00
Ardelyx (ARDX) United States $0.869B 0.00
Elite Pharmaceuticals (ELTP) United States $0.801B 0.00
Xeris Biopharma Holdings (XERS) United States $0.726B 0.00
Cronos Group (CRON) Canada $0.721B 0.00
Xencor (XNCR) United States $0.599B 0.00
KalVista Pharmaceuticals (KALV) United States $0.593B 0.00
Altimmune (ALT) United States $0.567B 0.00
USANA Health Sciences (USNA) United States $0.565B 12.29
Regulus Therapeutics (RGLS) United States $0.564B 0.00
Relay Therapeutics (RLAY) United States $0.554B 0.00
Bioventus (BVS) United States $0.536B 13.58
Theravance Biopharma (TBPH) United States $0.529B 0.00
Liminatus Pharma (LIMN) United States $0.520B 0.00
AleAnna (ANNA) United States $0.504B 0.00
Zevra Therapeutics (ZVRA) United States $0.492B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.447B 0.00
Siga Technologies (SIGA) United States $0.442B 9.24
Tourmaline Bio (TRML) United States $0.437B 0.00
Organogenesis (ORGO) United States $0.424B 0.00
Oruka Therapeutics (ORKA) United States $0.408B 0.00
Savara (SVRA) United States $0.373B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.337B 9.10
Aquestive Therapeutics (AQST) United States $0.327B 0.00
Heron Therapeutics (HRTX) United States $0.322B 0.00
Nature's Sunshine Products (NATR) United States $0.275B 25.27
Tonix Pharmaceuticals Holding (TNXP) United States $0.241B 0.00
Nanobiotix S.A (NBTX) France $0.208B 0.00
Esperion Therapeutics (ESPR) United States $0.206B 0.00
MediWound (MDWD) Israel $0.205B 0.00
OmniAb (OABI) United States $0.197B 0.00
Aldeyra Therapeutics (ALDX) United States $0.185B 0.00
Profound Medical (PROF) Canada $0.181B 0.00
ProKidney (PROK) United States $0.177B 0.00
4D Molecular Therapeutics (FDMT) United States $0.175B 0.00
Galectin Therapeutics (GALT) United States $0.157B 0.00
Larimar Therapeutics (LRMR) United States $0.155B 0.00
Aclaris Therapeutics (ACRS) United States $0.151B 0.00
Journey Medical (DERM) United States $0.149B 0.00
Innate Pharma SA (IPHYF) France $0.145B 0.00
Avita Medical (RCEL) United States $0.136B 0.00
Achieve Life Sciences (ACHV) Canada $0.133B 0.00
Lyell Immunopharma (LYEL) United States $0.133B 0.00
Lexeo Therapeutics (LXEO) United States $0.131B 0.00
VAXART, INC (VXRT) United States $0.128B 0.00
Inhibikase Therapeutics (IKT) United States $0.123B 0.00
Nektar Therapeutics (NKTR) United States $0.118B 0.00
Champions Oncology (CSBR) United States $0.111B 18.32
Protara Therapeutics (TARA) United States $0.111B 0.00
Korro Bio (KRRO) United States $0.110B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.109B 0.00
Cardiol Therapeutics (CRDL) Canada $0.106B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.097B 0.00
Cassava Sciences (SAVA) United States $0.091B 0.00
Unicycive Therapeutics (UNCY) United States $0.090B 0.00
Nutriband (NTRB) United States $0.086B 0.00
Arch Biopartners (ACHFF) Canada $0.081B 0.00
Dominari Holdings (DOMH) United States $0.080B 0.00
Fractyl Health (GUTS) United States $0.079B 0.00
Surrozen (SRZN) United States $0.077B 0.00
Wellgistics Health (WGRX) United States $0.077B 0.00
ESSA Pharma (EPIX) Canada $0.076B 0.00
Pyxis Oncology (PYXS) United States $0.075B 0.00
Vivani Medical (VANI) United States $0.075B 0.00
Inotiv (NOTV) United States $0.069B 0.00
Assertio Holdings (ASRT) United States $0.060B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.059B 43.67
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Rafael Holdings (RFL) United States $0.058B 0.00
PMV Pharmaceuticals (PMVP) United States $0.056B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.054B 0.00
NRx Pharmaceuticals (NRXP) United States $0.054B 0.00
Metagenomi (MGX) United States $0.053B 0.00
Avalo Therapeutics (AVTX) United States $0.052B 0.00
Gain Therapeutics (GANX) United States $0.051B 0.00
Context Therapeutics (CNTX) United States $0.051B 0.00
Telomir Pharmaceuticals (TELO) United States $0.050B 0.00
Century Therapeutics (IPSC) United States $0.050B 0.00
Prelude Therapeutics (PRLD) United States $0.047B 0.00
Mural Oncology (MURA) Ireland $0.043B 0.00
Jupiter Neurosciences (JUNS) United States $0.040B 0.00
Klotho Neurosciences (KLTO) United States $0.039B 0.00
ElectroCore (ECOR) United States $0.038B 0.00
Iterum Therapeutics (ITRM) Ireland $0.038B 0.00
PolyPid (PYPD) Israel $0.038B 0.00
Karyopharm Therapeutics (KPTI) United States $0.037B 0.00
Acrivon Therapeutics (ACRV) United States $0.037B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.032B 0.00
China SXT Pharmaceuticals (SXTC) China $0.029B 0.00
SCYNEXIS (SCYX) United States $0.028B 0.00
Enlivex Therapeutics (ENLV) Israel $0.027B 0.00
Tempest Therapeutics (TPST) United States $0.025B 0.00
FibroGen (FGEN) United States $0.022B 0.00
Natural Alternatives (NAII) United States $0.021B 0.00
Relmada Therapeutics (RLMD) United States $0.020B 0.00
DURECT (DRRX) United States $0.019B 0.00
Carisma Therapeutics (CARM) United States $0.019B 0.00
BioVie (BIVI) United States $0.019B 0.00
Ernexa Therapeutics (ERNA) United States $0.018B 0.00
Mannatech (MTEX) United States $0.017B 0.00
Vivos Therapeutics (VVOS) United States $0.017B 0.00
BioLineRx (BLRX) Israel $0.017B 0.00
Lipocine (LPCN) United States $0.017B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.016B 0.00
Lyra Therapeutics (LYRA) United States $0.015B 0.00
CASI Pharmaceuticals (CASI) China $0.015B 0.00
ProPhase Labs (PRPH) United States $0.014B 0.00
VYNE Therapeutics (VYNE) United States $0.014B 0.00
TherapeuticsMD (TXMD) United States $0.013B 0.00
Minerva Neurosciences (NERV) United States $0.012B 2.16
Cosmos Health (COSM) United States $0.012B 0.00
Scienture Holdings (SCNX) United States $0.012B 0.00
Citius Pharmaceuticals (CTXR) United States $0.011B 0.00
Phio Pharmaceuticals (PHIO) United States $0.010B 0.00
Ainos (AIMD) United States $0.010B 0.00
Mangoceuticals (MGRX) United States $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.010B 0.00
Talphera (TLPH) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Traws Pharma (TRAW) United States $0.009B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.008B 0.00
Indaptus Therapeutics (INDP) United States $0.008B 0.00
Biomerica (BMRA) United States $0.008B 0.00
Alaunos Therapeutics (TCRT) United States $0.007B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
TransCode Therapeutics (RNAZ) United States $0.006B 0.00
Incannex Healthcare (IXHL) Australia $0.006B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.006B 0.00
Aptorum Group (APM) United Kingdom $0.005B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
SHINECO (SISI) China $0.005B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
Plus Therapeutics (PSTV) United States $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
PainReform (PRFX) Israel $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.003B 0.00
Aditxt (ADTX) United States $0.003B 0.00
Jaguar Animal Health (JAGX) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Conduit Pharmaceuticals (CDT) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
GlycoMimetics (CBIO) United States $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00